Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence (Q33631450)

28 July 2017

1 reference

title

Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence (English)

1 reference

28 July 2017

van der Weijden T

1

1 reference

28 July 2017

Knottnerus JA

2

1 reference

28 July 2017

Ament AJ

3

1 reference

28 July 2017

Stoffers HE

4

1 reference

28 July 2017

Grol RP

5

1 reference

28 July 2017

1 September 1998

1 reference

Journal of Epidemiology and Community Health

28 July 2017

1 reference

28 July 2017

52

1 reference

28 July 2017

586-594

1 reference

28 July 2017

9

1 reference

Making cost assessments based on RCTs more useful to decision-makers

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Screening could seriously damage your health

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost-effectiveness of dietary treatment of hypercholesterolemia in Spain.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost effectiveness of personal health education in primary care for people with angina in the greater Belfast area of Northern Ireland.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost effectiveness of lowering cholesterol. Costs in general practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost-effectiveness of pravastatin in secondary prevention of coronary artery disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cholesterol-reduction intervention study (CRIS): a randomized trial to assess effectiveness and costs in clinical practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost-effectiveness of hypolipidaemic drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost-effectiveness analysis in heart disease, Part II: Preventive therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Strategies for reducing coronary risk factors in primary care: which is most cost effective?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Five-hundred life-saving interventions and their cost-effectiveness

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Psychological reactions to information about risk of ischaemic heart disease in general practice.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Labelling in hypertension: a review of the behavioural and psychological consequences

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Primary prevention and coronary heart disease: the economic benefits of lowering serum cholesterol.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Can health screening damage your health?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Effectiveness and hazards of case finding for a high cholesterol concentration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

How serious are the adverse effects of screening?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

A mathematical representation of the expert panel's guidelines for high blood cholesterol case-finding and treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

The economics of cholesterol lowering

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Gemfibrozil cost-benefit study. Targeting subgroups for effective hyperlipidaemia drug therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Primary prevention of coronary heart disease in the Federal Republic of Germany. Analysis of cost-effectiveness

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

A clinician's guide to cost-effectiveness analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

The design of future cost-benefit studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Medical management and managing medical care: the dilemma of evaluating new technology.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Outcome assessment in cardiovascular cost-benefit studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Costs and benefits of risk factor reduction for coronary heart disease: insights from screening and treatment of serum cholesterol

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Screening for hypercholesterolemia among Canadians: how much will it cost?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Strategies of prevention revisited: effects of imprecise measurement of risk factors on the evaluation of "high-risk" and "population-based" approaches to prevention of cardiovascular disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Costs and health consequences of cholesterol screening for asymptomatic older Americans.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Does cholesterol screening result in negative labeling effects? Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Work absenteeism in men who are labelled hypercholesterolaemic at screening

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost effectiveness of work-site cholesterol screening and intervention programs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost and health implications of cholesterol lowering

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Precision of blood cholesterol measurement and high blood cholesterol case-finding and treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

First principles of cost-effectiveness analysis in health

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Effect of biological and analytical variation in cholesterol measurement on the cost-effectiveness of cholesterol-lowering therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Time-dependent variability in repeated measurements of cholesterol levels: clinical implications for risk misclassification and intervention monitoring.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Combination drug therapy for hypercholesterolemia. The trade-off between cost and simplicity.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Designing a simpler high blood cholesterol case detection strategy: are the advantages of the NCEP protocol worth the complexity?

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Modelling different strategies to prevent coronary heart disease in primary care.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

A randomized trial to assess effectiveness and cost in clinical practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Benefits and costs of medical nutrition therapy by registered dietitians for patients with hypercholesterolemia. Massachusetts Dietetic Association.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Replacing lovastatin with pravastatin: effect on serum lipids and costs.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756760

Estimating costs in the economic evaluation of medical technologies

30 October 2018

1 reference

12 December 2020

Impact of a public cholesterol screening program

1 reference

12 December 2020

Hypercholesterolemia: the cost of treatment in perspective

1 reference

12 December 2020

Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction

1 reference

12 December 2020

Comparison of an Aggressive (U.S.) and a Less Aggressive (Canadian) Policy for Cholesterol Screening and Treatment

1 reference

12 December 2020

Psychologic effects of the diagnosis and treatment of hypercholesterolemia: Lessons from case studies

1 reference

12 December 2020

Cholesterol: truth in labeling

1 reference

12 December 2020

Compliance with medication in the Helsinki Heart Study

1 reference

12 December 2020

Efficacy and cost-effectiveness of simvastatin and gemfibrozil in the treatment of hyperlipidaemia

1 reference

12 December 2020

A model for evaluating the cost-effectiveness of cholesterol-lowering treatment

1 reference

12 December 2020

Standardizing methodologies for economic evaluation in health care. Practice, problems, and potential

1 reference

12 December 2020

Evaluating cholesterol screening. The importance of controlling for regression to the mean

1 reference

12 December 2020

Cost of prevention. The case of lipid lowering

1 reference

12 December 2020

Cholesterol, children, and heart disease: an analysis of alternatives

1 reference

12 December 2020

Free care, cholestyramine, and health policy

1 reference

12 December 2020

Cost-effectiveness of interventions to prevent or treat coronary heart disease

1 reference

12 December 2020

The measurement iterative loop: A framework for the critical appraisal of need, benefits and costs of health interventions

1 reference

12 December 2020

Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine

1 reference

12 December 2020

Cost studies: caveats to the reader

1 reference

12 December 2020

A cost-effectiveness analysis of alternative strategies for the prevention of heart disease

1 reference

12 December 2020

Community-based cholesterol screening and education to prevent heart disease: five-year results of the North Coast Cholesterol Check Campaign

1 reference

12 December 2020

Selection of end points in economic evaluations of coronary-heart-disease interventions

1 reference

12 December 2020

The cost of screening for hypercholesterolaemia– results from a clinical trial in Swedish primary health care

1 reference

12 December 2020

Intervention against ischaemic heart disease risk factors in primary health care in a semi-rural community. The population study "50-year-old people in Kungsör"

1 reference

12 December 2020

Clinical decision making: from theory to practice. Rationing resources while improving quality. How to get more for less

1 reference

12 December 2020

Cost-effectiveness of simvastatin versus cholestyramine: results for Sweden

1 reference

12 December 2020

Enhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapy

1 reference

12 December 2020

The costs and effects of two different lipid intervention programmes in primary health care

1 reference

12 December 2020

Pharmaco-economic assessment of the HMG-CoA reductase inhibitors

1 reference

12 December 2020

Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia

1 reference

12 December 2020

Identifiers

DOI

10.1136/JECH.52.9.586

1 reference

28 July 2017

1 reference

28 July 2017

1 reference